This trial tests whether intravenous tenecteplase thrombolysis initiated between 4.5 and 24 hours after symptom onset benefits patients with acute ischemic stroke due to non–large vessel occlusion with evidence of salvageable brain tissue.
JAMA (Journal of the American Medical Association) published a clinical update in Research Highlights on 07 Apr 2026.
The item focuses on Tenecteplase for Acute Non–Large Vessel Occlusion 4.5 to 24 Hours After Ischemic Stroke Onset.
Review the original article for the full source wording and details.